About Embolx
Embolx is a company based in Sunnyvale (United States) founded in 2013. It operates as a Direct-to-Consumer (D2C), and HealthTech. Embolx has raised $500 thousand across 3 funding rounds from investors including HHS. Embolx offers products and services including Sniper Balloon Occlusion Microcatheter, Soldier High Flow Microcatheter, and Sniper G3 Balloon Occlusion Microcatheter. Embolx operates in a competitive market with competitors including Augmedics, TriSalus Life Sciences, Proprio, ClearPoint Neuro and IMRIS Deerfield Imaging, among others.
- Headquarter Sunnyvale, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Embolx, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$500 K (USD)
in 3 rounds
-
Latest Funding Round
$1.86 M (USD), Grant
Sep 25, 2015
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Embolx
Embolx offers a comprehensive portfolio of products and services, including Sniper Balloon Occlusion Microcatheter, Soldier High Flow Microcatheter, and Sniper G3 Balloon Occlusion Microcatheter. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Used for targeted arterial embolization in medical procedures.
Designed for high-flow delivery in embolization treatments.
Enhanced microcatheter for efficient and targeted embolization.
Unlock access to complete
Unlock access to complete
Funding Insights of Embolx
Embolx has successfully raised a total of $500K across 3 strategic funding rounds. The most recent funding activity was a Grant round of $1.86 million completed in September 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $1.9M
-
First Round
First Round
(04 Feb 2014)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2015 | Amount | Grant - Embolx | Valuation |
investors |
|
| May, 2014 | Amount | Seed - Embolx | Valuation |
investors |
|
| Feb, 2014 | Amount | Seed - Embolx | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Embolx
Embolx has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Embolx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Embolx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Embolx Comparisons
Competitors of Embolx
Embolx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Augmedics, TriSalus Life Sciences, Proprio, ClearPoint Neuro and IMRIS Deerfield Imaging, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Augmented reality systems for guiding surgical procedures are developed.
|
|
| domain | founded_year | HQ Location |
Developer of drug delivery devices to treat cancers
|
|
| domain | founded_year | HQ Location |
Visualization systems for surgical procedures are developed using machine learning.
|
|
| domain | founded_year | HQ Location |
Software and hardware solutions for MRI-guided surgical planning are provided.
|
|
| domain | founded_year | HQ Location |
Surgical theatres with ceiling mounted mobile imaging devices to enhance intraoperative workflow
|
|
| domain | founded_year | HQ Location |
Robotic surgery platform for bone procedures is developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Embolx
Frequently Asked Questions about Embolx
When was Embolx founded?
Embolx was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Embolx located?
Embolx is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Is Embolx a funded company?
Embolx is a funded company, having raised a total of $500K across 3 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on Feb 04, 2014.
What does Embolx do?
Embolx is engaged in the development and innovation of microcatheters for arterial embolization procedures. Solutions are provided for targeted medical interventions using high-pressure and low-pressure techniques. The healthcare sector, specifically interventional radiology, is served through products like the Sniper Balloon Occlusion Microcatheter and Soldier High Flow Microcatheter. Advancements are continuously made, as seen with the release of the Sniper G3, enhancing efficiency and usability in medical treatments.
Who are the top competitors of Embolx?
Embolx's top competitors include Augmedics, Proprio and TriSalus Life Sciences.
What products or services does Embolx offer?
Embolx offers Sniper Balloon Occlusion Microcatheter, Soldier High Flow Microcatheter, and Sniper G3 Balloon Occlusion Microcatheter.
Who are Embolx's investors?
Embolx has 1 investor. Key investors include HHS.